Clinical Drug Experience Knowledgebase

Aggression (Phase 2)

Breast Neoplasms (Phase 2)

Burkitt Lymphoma (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Colorectal Neoplasms (Phase 2)

Disease Progression (Phase 2)

Graft vs Host Disease (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Myeloma (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Ovarian Neoplasms (Phase 2)

Preleukemia (Phase 2)

Rectal Neoplasms (Phase 2)

Syndrome (Phase 2)

Thrombocytopenia (Phase 2)

Urinary Bladder Neoplasms (Phase 2)